Shai Shimony

41PUBLICATIONS
166CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Oct 15, 2026
Flow MRD pre-blinatumomab consolidation, despite subsequent clearance, is associated with inferior survival in Ph+ B-ALL.

|Sep 25, 2026
Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia.

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 07, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

|Apr 20, 2026
The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.

|Feb 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson

Pageof 7

Frequent Collaborators

22 joint publications

Marlise R Luskin

14 joint publications

Daniel J DeAngelo

11 joint publications

Jacqueline S Garcia

7 joint publications

Richard M Stone